Scinai Immunotherapeutics Ltd.

Biotechnology company · Jerusalem, Israel · Nasdaq: SCNI

Scinai Immunotherapeutics Ltd. is a biotechnology company headquartered in Jerusalem, Israel. Its shares trade on Nasdaq under the ticker SCNI. It has reported private securities offerings to the US SEC, most recently $1.7 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Scinai Immunotherapeutics at a glance

Typebiotechnology company

HeadquartersJerusalem, Israel

Stock listingNasdaq: SCNI

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1611747

What does Scinai Immunotherapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $1.7 million sold (2024).

Frequently asked questions about Scinai Immunotherapeutics

Where is Scinai Immunotherapeutics headquartered?

Scinai Immunotherapeutics Ltd. is headquartered in Jerusalem, Israel.

What does Scinai Immunotherapeutics do?

Scinai Immunotherapeutics Ltd. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Scinai Immunotherapeutics a public company?

Yes. Scinai Immunotherapeutics Ltd. trades on Nasdaq under the ticker SCNI.

Similar companies

Entera Bio Ltd.Jerusalem, Israel
Gamida Cell Ltd.Jerusalem, Israel
Cellsound Aesthetics LTDJerusalem, Israel
Compugen LtdH̱olon, Tel Aviv, Israel
Pluri Inc.Haifa, Israel
Silexion Therapeutics CorpRamat Gan, Tel Aviv, Israel
Atox Bio Inc.Ness Ziona, Central District, Israel
Check-Cap Ltd‘Isfiyā, Haifa, Israel

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences